Newsroom

Sorted by: Latest
-

Approval by the Combined Shareholders' Meeting of December 10, 2025 of the Transfer of Claranova Shares from Euronext Paris to Euronext Growth Paris

PARIS--(BUSINESS WIRE)--Regulatory News: The Board of Directors of Claranova (Euronext Paris: FR0013426004 - CLA or the "Company"), meeting on October 28, 2025, has decided to submit to the next Combined General Meeting of Shareholders, to be held on December 10, 2025, as part of its ordinary session, the approval of the proposed transfer of its securities from the regulated market of Euronext Paris (Compartment C) to the multilateral trading facility of Euronext Growth Paris. The combined gene...
-

Approbation par l'Assemblée Générale Mixte du 10 décembre 2025 du transfert de cotation des titres Claranova du marché Euronext Paris vers Euronext Growth Paris

PARIS--(BUSINESS WIRE)--Regulatory News: L’assemblée générale mixte des actionnaires de Claranova (Euronext Paris : FR0013426004 - CLA ou la « Société »), réunie ce jour, a approuvé, conformément aux dispositions de l’article L. 421-14 du Code de commerce, le projet de transfert de cotation de ses titres du marché réglementé d’Euronext Paris (Compartiment C) vers le marché d’Euronext Growth Paris, et conféré tous pouvoirs au Conseil d’administration à l’effet de mettre en œuvre ce transfert de...
-

Rosen Law Firm Urges Bitdeer Technologies Group (NASDAQ: BTDR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers and acquirers of Bitdeer Technologies Group (NASDAQ: BTDR) securities between June 6, 2024 and November 10, 2025, both dates inclusive (the “Class Period”). Bitdeer is a bitcoin mining and high-performance computing (HPC) data-center infrastructure company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Al...
-

Le Cleveland Clinic Neurological Institute et le Baszucki Group s'associent pour faire avancer une étude historique sur le cerveau à l'aide de marqueurs métaboliques de santé

SAN MATEO, Calif.--(BUSINESS WIRE)--Baszucki Group a annoncé aujourd’hui un engagement accru envers l'étude historique sur le cerveau menée par la Cleveland Clinic. Lancée en 2022, cette ambitieuse étude longitudinale prévoit de suivre des personnes en bonne santé sur une période de 20 ans afin d’identifier des marqueurs précoces de maladies et des cibles thérapeutiques nécessaires pour prévenir – et finalement guérir – les maladies neurologiques. L’engagement de Baszucki Group porte son don to...
-

El Instituto Neurológico de Cleveland Clinic y el Grupo Baszucki unen fuerzas para impulsar un estudio cerebral de referencia con marcadores de la salud metabólica

SAN MATEO, California--(BUSINESS WIRE)--El Grupo Baszucki anunció hoy la ampliación de su compromiso con el estudio cerebral de referencia de Cleveland Clinic. Lanzado en 2022, este ambicioso estudio longitudinal planea realizar un seguimiento de individuos sanos durante un período de 20 años con la meta de identificar los marcadores de enfermedad tempranos y los objetivos terapéuticos necesarios para prevenir y, en última instancia, curar trastornos neurológicos. El compromiso de Baszucki Grou...
-

Cleveland Clinic Neurological Institute und Baszucki Group schließen sich zusammen, um wegweisende Hirnstudie mit metabolischen Gesundheitsmarkern voranzutreiben

SAN MATEO, Kalifornien--(BUSINESS WIRE)--Die Baszucki Group kündigte heute ihr verstärktes Engagement für die wegweisende Cleveland Clinic Brain Study an. Im Rahmen dieser ehrgeizigen Langzeitstudie, die 2022 ins Leben gerufen wurde, werden gesunde Personen über einen Zeitraum von 20 Jahren beobachtet, um frühe Krankheitsmarker und therapeutische Angriffspunkte zu identifizieren, die zur Prävention und letztendlichen Heilung neurologischer Erkrankungen erforderlich sind. Die Zusage der Baszucki...
-

Citibank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: SNB FUNDING LIMITED USD 750,000,000.00 MATURING: 18-Mar-2030 ISIN: XS3019019416 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 17-Sep-2025 TO 17-Dec-2025 HAS BEEN FIXED AT 5.34 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 17-Dec-2025 WILL AMOUNT TO: USD 13.50 PER USD 1,000.00 DENOMINATION  ...
-

Citibank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: The Bank of Nova Scotia GBP 1,500,000,000.00 MATURING: 15-Sep-2028 ISIN: XS3181511059 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 15-Sep-2025 TO 15-Dec-2025 HAS BEEN FIXED AT 4.53 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 15-Dec-2025 WILL AMOUNT TO: GBP 16,933,142.88 PER GBP 1,500,000,000.00 DENOMINATION  ...
-

Data Center Accelerators Market Outlook Report 2025-2030 with Case Study Analysis: Global Investments Rise - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Data Center Accelerator Market by Processor (GPU, CPU, ASIC, FPGA), Type (Cloud Data Center, HPC Data Center), Application (Deep Learning Training, Enterprise Inference), End-user (IT & Telecom, Healthcare, Energy) and Region - Global Forecast to 2030" has been added to ResearchAndMarkets.com's offering. The data center accelerator market is projected to soar significantly, reaching USD 170.81 billion in 2025 and USD 372.68 billion by 2030, with a CAGR of 16.9%...
-

Citibank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: Lloyds Bank Corporate Markets plc USD 20,000,000.00 MATURING: 17-Dec-2027 ISIN: XS2843830956 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 17-Sep-2025 TO 17-Dec-2025 HAS BEEN FIXED AT 4.89 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 17-Dec-2025 WILL AMOUNT TO: USD 2,472.76 PER USD 200,000.00 DENOMINATION  ...